Northview Acquisition CORP Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
Hrt Financial Lp reported changes in beneficial ownership of NorthView Acquisition Corp common stock on July 28, 2026.
Hrt Financial Lp reported changes in beneficial ownership of NorthView Acquisition Corp common stock on July 28, 2026.
Hrt Financial Lp reported changes in beneficial ownership of NorthView Acquisition Corp common stock on July 28, 2026.
Hrt Financial Lp reported changes in beneficial ownership of NorthView Acquisition Corp common stock on July 28, 2026.
Hrt Financial Lp reported changes in beneficial ownership of NorthView Acquisition Corp common stock on July 28, 2026.
Hrt Financial Lp reported changes in beneficial ownership of NorthView Acquisition Corp common stock on July 28, 2026.
Profusa, Inc. Director Jack E. Stover reports the conversion of a promissory note into a significant number of common shares.
CFO Fred Knechtel reported the conversion of a $1.87 million promissory note into 5.34 million shares of Profusa common stock.
Profusa's Chief Financial Officer, Fred S. Knechtel, received a substantial distribution of common stock and warrants from NorthView Sponsor I LLC.
NorthView Sponsor I, LLC distributed 4.74 million shares of Profusa common stock and 5.16 million warrants to its members for no consideration.
Profusa, Inc. Director Peter O'Rourke received 107,750 shares of common stock and 15,250 warrants through a pro rata distribution from NorthView Sponsor I LLC.
Profusa Director Jack E. Stover received 553,665 shares of common stock and 380,280 warrants through a pro rata distribution from NorthView Sponsor I LLC.
Profusa Director Lauren Chung reported a planned acquisition of 30,000 common shares on January 26, 2026, through a pro rata distribution from NorthView Sponsor I LLC.
Profusa, Inc. Director Jack Stover received awards of stock options to purchase common stock, aligning his interests with shareholders.
Profusa Director Rajesh Asarpota received 274,660 stock options with an exercise price of $0.35, vesting over one to three years.
Profusa, Inc. Director Lauren Chung was granted 274,660 stock options with an exercise price of $0.35, vesting over one to three years.
Profusa, Inc. Director Peter O'Rourke was granted 274,660 stock options with an exercise price of $0.35, vesting over three years and one year respectively.
NorthView Acquisition Corp. announced further amendments to its merger agreement with Profusa, Inc., entered into a non-redemption agreement to bolster its trust account, and adjourned its special shareholder meeting to approve the business combination.
NorthView Acquisition Corp. enters into a non-redemption agreement with I-Bankers Securities and Dawson James Securities to maintain a minimum trust account balance of $1.25 million for its merger with Profusa, Inc.
NorthView Acquisition Corp. revises its merger agreement with Profusa, extending milestone deadlines and adjusting financial targets, while also securing a $22.2 million convertible note financing to support the business combination.
Profusa, a bio-engineered sensor company, is seeking to go public through a business combination with NorthView Acquisition Corp. to further develop and commercialize its real-time body chemistry monitoring technology.
425: NorthView Acquisition Corp. Amends Merger Agreement with Profusa to Adjust Company Reference Value
NorthView Acquisition Corp. and Profusa amend their merger agreement to revise the definition of 'Company Reference Value' to account for financing proceeds and debt conversions received by Profusa before the business combination.